| abstract |
The present invention relates to peptides, proteins, nucleic acids and cells for use in nimmunotherapeutic methods. In particular, the present invention relates to the nimmunotherapy of cancer. The present invention furthermore relates to tumornassociated T-cell peptide epitopes, alone or in combination with other tumor-associated npeptides that can for example serve as active pharmaceutical ingredients of vaccine ncompositions that stimulate anti-tumor immune responses, or to stimulate T cells ex vivo nand transfer into patients. Peptides bound to molecules of the major histocompatibility ncomplex (MHC), or peptides as such, can also be targets of antibodies, soluble T-cell nreceptors, and other binding molecules. |